Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 26
Filtrar
1.
Microbiologyopen ; 7(1)2018 02.
Artículo en Inglés | MEDLINE | ID: mdl-28921941

RESUMEN

Strains of Lactococcus lactis isolated from plant tissues possess adaptations that support their survival and growth in plant-associated microbial habitats. We previously demonstrated that genes coding for a hybrid nonribosomal peptide synthetase/polyketide synthase (NRPS/PKS) system involved in production of an uncharacterized secondary metabolite are specifically induced in L. lactis KF147 during growth on plant tissues. Notably, this NRPS/PKS has only been identified in plant-isolated strains of L. lactis. Here, we show that the L. lactis KF147 NRPS/PKS genes have homologs in certain Streptococcus mutans isolates and the genetic organization of the NRPS/PKS locus is conserved among L. lactis strains. Using an L. lactis KF147 mutant deficient in synthesis of NrpC, a 4'-phosphopantetheinyl transferase, we found that the NRPS/PKS system improves L. lactis during growth under oxidative conditions in Arapidopsis thaliana leaf lysate. The NRPS/PKS system also improves tolerance of L. lactis to reactive oxygen species and specifically H2 O2 and superoxide radicals in culture medium. These findings indicate that this secondary metabolite provides a novel mechanism for reactive oxygen species detoxification not previously known for this species.


Asunto(s)
Lactococcus lactis/enzimología , Estrés Oxidativo , Péptido Sintasas/metabolismo , Extractos Vegetales/metabolismo , Hojas de la Planta/química , Sintasas Poliquetidas/metabolismo , Estrés Fisiológico , Secuencia Conservada , Peróxido de Hidrógeno/toxicidad , Lactococcus lactis/genética , Lactococcus lactis/crecimiento & desarrollo , Péptido Sintasas/genética , Sintasas Poliquetidas/genética , Especies Reactivas de Oxígeno/toxicidad , Homología de Secuencia , Streptococcus mutans/enzimología , Streptococcus mutans/genética
2.
Langmuir ; 32(35): 8988-98, 2016 09 06.
Artículo en Inglés | MEDLINE | ID: mdl-27501392

RESUMEN

Water-in-oil (W/O) microemulsions based on either refined olive oil (ROO) or sunflower oil (SO), distilled monoglycerides (DMG), and ethanol were used as nisin carriers in order to ensure its effectiveness as a biopreservative. This work presents experimental evidence on the effects of ethanol concentration, hydration, the nature of oil, and the addition of nisin on the nanostructure of the proposed inverse microemulsions as revealed by electrical conductivity measurements, dynamic light scattering (DLS), small angle X-ray scattering (SAXS), and electron paramagnetic resonance (EPR) spectroscopy. Modeling of representative SAXS profiles was applied to gain further insight into the effects of ethanol and solubilized water content on the inverse swollen micelles' size and morphology. With increasing ethanol content, the overall size of the inverse micelles decreased, whereas hydration resulted in an increase in the micellar size due to the penetration of water into the hydrophilic core of the inverse swollen micelles (hydration-induced swelling behavior). The dynamic properties of the surfactant monolayer were also affected by the nature of the used vegetable oil, the ethanol content, and the presence of the bioactive molecule, as evidenced by EPR spin probing experiments. According to simulation on the experimental spectra, two populations of spin probes at different polarities were revealed. The antimicrobial effect of the encapsulated nisin was evaluated using the well diffusion assay (WDA) technique against Lactococccus lactis. It was found that this encapsulated bacteriocin induced an inhibition of the microorganism growth. The effect was more pronounced at higher ethanol concentrations, but no significant difference was observed between the two used vegetable oils (ROO and SO).


Asunto(s)
Portadores de Fármacos , Etanol/química , Lactococcus lactis/efectos de los fármacos , Nisina/farmacología , Agua/química , Conductividad Eléctrica , Emulsiones , Lactococcus lactis/crecimiento & desarrollo , Micelas , Monoglicéridos/química , Nisina/química , Aceite de Oliva/química , Marcadores de Spin , Aceite de Girasol/química
3.
Appl Microbiol Biotechnol ; 100(18): 7899-908, 2016 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-27112347

RESUMEN

Nisin production by Lactococcus lactis CECT 539 was followed in batch cultures in whey supplemented with different concentrations of glucose and in two realkalized fed-batch fermentations in unsupplemented whey, which were fed, respectively, with concentrated solutions of lactose and glucose. In the batch fermentations, supplementation of whey with glucose inhibited both the growth and bacteriocin production. However, fed-batch cultures were characterized with high productions of biomass (1.34 and 1.51 g l(-1)) and nisin (50.6 and 60.3 BU ml(-1)) in comparison to the batch fermentations in unsupplemented whey (0.48 g l(-1) and 22.5 BU ml(-1)) and MRS broth (1.59 g l(-1) and 50.0 BU ml(-1)). In the two realkalized fed-batch fermentations, the increase in bacteriocin production parallels both the biomass production and pH drop generated in each realkalization and feeding cycle, suggesting that nisin was synthesized as a pH-dependent primary metabolite. A shift from homolactic to heterolactic fermentation was observed at the 108 h of incubation, and other metabolites (acetic acid and butane-2,3-diol) in addition to lactic acid accumulated in the medium. On the other hand, the feeding with glucose improved the efficiencies in glucose, nitrogen, and phosphorus consumption as compared to the batch cultures. The realkalized fed-batch fermentations showed to be an effective strategy to enhance nisin production in whey by using an appropriate feeding strategy to avoid the substrate inhibition.


Asunto(s)
Medios de Cultivo/química , Glucosa/metabolismo , Lactococcus lactis/metabolismo , Lactosa/metabolismo , Nisina/metabolismo , Suero Lácteo/metabolismo , Técnicas de Cultivo Celular por Lotes , Fermentación , Concentración de Iones de Hidrógeno , Lactococcus lactis/crecimiento & desarrollo , Nitrógeno/metabolismo , Fósforo/metabolismo
4.
Acta Sci Pol Technol Aliment ; 15(1): 37-45, 2016.
Artículo en Inglés | MEDLINE | ID: mdl-28071037

RESUMEN

BACKGROUND: In the process of enrichment of dairy products a priority element is the proper selection of compounds that are a mineral carrier. Calcium bisglycinate is better absorbed by the body than inorganic forms of calcium. Moreover, the lactic acid which is produced in kefir fermentation and the presence of lactose have also a positive effect on the improvement of absorption of calcium. The aim of the present study was to determine the influence of the applied dose of calcium in the form of calcium bisglycinate on the physicochemical and sensory properties and texture of kefirs during 21-day period of cold storage. METHODS: Processed cow milk was enriched with 0, 5, 10, 15, 20, 25 and 30 mg of calcium (for 100 g of milk), repasteurized (72°C, 1 min), cooled down (26°C), inoculated with Commercial VITAL kefir culture (Danisco, Poland) and fermented for 16 hours (26°C). The assessment of the influence of addition   of calcium bisglycinate on acidity, syneresis, texture and sensory characteristics (1-9 points) of kefirs was conducted at four fixed dates (after 1 day, 7 days, 14 days and 21 days of storage). RESULTS: During successive weeks of cold storage in all experimental groups there was observed a tendency to decrease general acidity. On the 1st and 7th days of cold storage reduced whey leakage was observed in kefirs enriched with 25 mg and 30 mg Ca/100 g of milk. With increasing doses of enrichment with calcium both the hardness, adhesiveness and gumminess of kefirs decreased. The applied doses of calcium did not cause changes in the sensory characteristics such as colour and consistency of the fermented beverages. CONCLUSIONS: Calcium bisglycinate may be used to enrich kefirs with calcium even with 30 mg of calcium in 100 g of milk without the modification of the product's parameters.


Asunto(s)
Calcio de la Dieta/análisis , Calidad de los Alimentos , Almacenamiento de Alimentos , Alimentos Fortificados/análisis , Glicina/química , Kéfir/análisis , Compuestos Organometálicos/química , Adhesividad , Fenómenos Químicos , Fermentación , Alimentos Fortificados/microbiología , Dureza , Humanos , Concentración de Iones de Hidrógeno , Kéfir/microbiología , Lactobacillus acidophilus/crecimiento & desarrollo , Lactobacillus acidophilus/metabolismo , Lactococcus lactis/crecimiento & desarrollo , Lactococcus lactis/metabolismo , Leuconostoc/crecimiento & desarrollo , Leuconostoc/metabolismo , Fenómenos Mecánicos , Pasteurización , Sensación , Streptococcus thermophilus/crecimiento & desarrollo , Streptococcus thermophilus/metabolismo , Simbiosis , Levaduras/crecimiento & desarrollo , Levaduras/metabolismo
5.
J Sci Food Agric ; 96(9): 3180-7, 2016 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-26459934

RESUMEN

BACKGROUND: Cow milk allergy is the most common food allergy in children. So far, no effective treatment is available to prevent or cure food allergy. This study investigated whether orally administrated probiotics could suppress sensitisation in whey proteins (WP)-induced allergy mouse model. Two types of probiotic Dahi were prepared by co-culturing Dahi bacteria (Lactococcus lactis ssp. cremoris NCDC-86 and Lactococcus lactis ssp. lactis biovar diacetylactis NCDC-60) along with selected strain of Lactobacillus acidophilus LaVK2 and Bifidobacterium bifidum BbVK3. Mice were fed with probiotic Dahi (La-Dahi and LaBb-Dahi) from 7 days before sensitisation with WP, respectively, in addition to milk protein-free basal diet, and control group received no supplements. RESULTS: Feeding of probiotic Dahi suppressed the elevation of whey proteins-specific IgE and IgG response of WP-sensitised mice. In addition, sIgA levels were significantly (P < 0.001) increased in intestinal fluid collected from mice fed with La-Dahi. Production of T helper (Th)-1 cell-specific cytokines, i.e. interferon-γ (IFN-γ), interleukin (IL)-12, and IL-10 increased, while Th2-specific cytokines, i.e. IL-4 decreased in the supernatant of cultured splenocytes collected from mice fed with probiotic Dahi as compared to the other groups. Moreover, the splenic mRNA levels of IFN-γ, interleukin-10 were found to be significantly increased, while that of IL-4 decreased significantly in La-Dahi groups, as compared to control groups. CONCLUSION: Results of the present study indicate that probiotic Dahi skewed Th2-specific immune response towards Th1-specific response and suppressed IgE in serum. Collectively, this study shows the potential use of probiotics intervention in reducing the allergic response to whey proteins in mice. © 2015 Society of Chemical Industry.


Asunto(s)
Bifidobacterium bifidum/inmunología , Citocinas/biosíntesis , Inmunoglobulinas/sangre , Lactobacillus acidophilus/inmunología , Probióticos/farmacología , Alimentación Animal/microbiología , Animales , Línea Celular , Citocinas/inmunología , Suplementos Dietéticos , Modelos Animales de Enfermedad , Hipersensibilidad a los Alimentos/dietoterapia , Hipersensibilidad a los Alimentos/prevención & control , Intestinos/inmunología , Lactococcus lactis/crecimiento & desarrollo , Masculino , Ratones , Hipersensibilidad a la Leche/tratamiento farmacológico , Hipersensibilidad a la Leche/microbiología , ARN Mensajero/análisis , ARN Mensajero/aislamiento & purificación , Bazo/inmunología , Proteína de Suero de Leche/inmunología , Proteína de Suero de Leche/farmacología
6.
Hum Vaccin Immunother ; 10(6): 1611-21, 2014.
Artículo en Inglés | MEDLINE | ID: mdl-24732667

RESUMEN

Irritable bowel syndrome (IBS) is a gastrointestinal disorder characterized by chronic abdominal pain, discomfort, and bloating. Interestingly, there is now evidence of the presence of a low-grade inflammatory status in many IBS patients, including histopathological and mucosal cytokine levels in the colon, as well as the presence of IBS-like symptoms in quiescent inflammatory bowel disease (IBD). The use of a genetically engineered food-grade bacterium, such as Lactococcus lactis, secreting the anti-inflammatory cytokine IL-10 has been proven by many pre-clinical studies to be a successful therapy to treat colon inflammation. In this study, we first reproduced the recovery-recurrence periods observed in IBS-patients in a new chronic model characterized by 2 episodes of DiNitro-BenzeneSulfonic-acid (DNBS)-challenge and we tested the effects of a recombinant strain of L. lactis secreting IL-10 under a Stress-Inducible Controlled Expression (SICE) system. In vivo gut permeability, colonic serotonin levels, cytokine profiles, and spleen cell populations were then measured as readouts of a low-grade inflammation. In addition, since there is increasing evidence that gut microbiota tightly regulates gut barrier function, tight junction proteins were also measured by qRT-PCR after administration of recombinant L. lactis in DNBS-treated mice. Strikingly, oral administration of L. lactis secreting active IL-10 in mice resulted in significant protective effects in terms of permeability, immune activation, and gut-function parameters. Although genetically engineered bacteria are, for now, used only as a "proof-of-concept," our study validates the interest in the use of the novel SICE system in L. lactis to express therapeutic molecules, such as IL-10, locally at mucosal surfaces.


Asunto(s)
Terapia Biológica/métodos , Colitis/terapia , Factores Inmunológicos/inmunología , Inmunoterapia/métodos , Interleucina-10/inmunología , Lactococcus lactis/metabolismo , Animales , Colitis/patología , Citocinas/análisis , Modelos Animales de Enfermedad , Perfilación de la Expresión Génica , Humanos , Factores Inmunológicos/genética , Factores Inmunológicos/metabolismo , Interleucina-10/genética , Interleucina-10/metabolismo , Lactococcus lactis/genética , Lactococcus lactis/crecimiento & desarrollo , Masculino , Ratones Endogámicos C57BL , Reacción en Cadena en Tiempo Real de la Polimerasa , Proteínas Recombinantes/genética , Proteínas Recombinantes/inmunología , Proteínas Recombinantes/metabolismo , Serotonina/análisis , Bazo/inmunología , Resultado del Tratamiento
7.
J Chem Inf Model ; 53(10): 2774-9, 2013 Oct 28.
Artículo en Inglés | MEDLINE | ID: mdl-24099460

RESUMEN

The momentum gained by research on biologics has not been met yet with equal thrust on the informatics side. There is a noticeable lack of software for data management that empowers the bench scientists working on the development of biologic therapeutics. SARvision|Biologics is a tool to analyze data associated with biopolymers, including peptides, antibodies, and protein therapeutics programs. The program brings under a single user interface tools to filter, mine, and visualize data as well as those algorithms needed to organize sequences. As part of the data-analysis tools, we introduce two new concepts: mutation cliffs and invariant maps. Invariant maps show the variability of properties when a monomer is maintained constant in a position of the biopolymer. Mutation cliff maps draw attention to pairs of sequences where a single or limited number of point mutations elicit a large change in a property of interest. We illustrate the program and its applications using a peptide data set collected from the literature.


Asunto(s)
Algoritmos , Productos Biológicos/farmacología , Biología Computacional/métodos , Interfaz Usuario-Computador , Antibacterianos/química , Antibacterianos/farmacología , Anticuerpos/química , Anticuerpos/farmacología , Productos Biológicos/química , Biomarcadores Farmacológicos , Biología Computacional/instrumentación , Biología Computacional/estadística & datos numéricos , Humanos , Lactococcus lactis/efectos de los fármacos , Lactococcus lactis/genética , Lactococcus lactis/crecimiento & desarrollo , Pruebas de Sensibilidad Microbiana , Micrococcus luteus/efectos de los fármacos , Micrococcus luteus/genética , Micrococcus luteus/crecimiento & desarrollo , Péptidos/química , Péptidos/farmacología , Mutación Puntual , Staphylococcus aureus/efectos de los fármacos , Staphylococcus aureus/genética , Staphylococcus aureus/crecimiento & desarrollo , Relación Estructura-Actividad
8.
Food Microbiol ; 29(1): 27-32, 2012 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-22029915

RESUMEN

Flavour development in cheese is affected by the integrity of Lactococcus lactis cells. Disintegrated cells enhance for instance the enzymatic degradation of casein to free amino acids, while integer cells are needed to produce specific flavour compounds from amino acids. The impact of the cellular activity of these integer cells on flavour production remains to be elucidated. In this study we investigated whether lactose-deprived L. lactis cells that use arginine as an alternative energy source can extend cellular activity and produce more specific flavours. In cheese experiments we demonstrated that arginine metabolising cells survived about 3 times longer than non-arginine metabolising cells, which suggests prolonged cellular activity. Cellular activity and flavour production of L. lactis was further studied in vitro to enable controlled arginine supplementation. Comparable with the results found in cheese, the survival rates of in vitro incubated cells improved when arginine was metabolised. Furthermore, elongated cellular activity was reflected in 3-4-fold increased activity of flavour generating enzymes. The observed prolonged cellular activity resulted in about 2-fold higher concentrations of typical Gouda cheese flavours. These findings provide new leads for composing starter cultures that will produce specific flavour compounds.


Asunto(s)
Arginina/metabolismo , Queso/análisis , Queso/microbiología , Aromatizantes/metabolismo , Lactococcus lactis/crecimiento & desarrollo , Lactococcus lactis/metabolismo , Aromatizantes/análisis , Lactosa/análisis , Lactosa/metabolismo , Viabilidad Microbiana
9.
Bioresour Technol ; 102(17): 8046-51, 2011 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-21683588

RESUMEN

Spent mushroom substrate (SMS) was treated with dilute sulfuric acid followed by cellulase and xylanase treatment to produce hydrolysates that could be used as the basis for media for the production of value added products. A L9 (3(4)) orthogonal experiment was performed to optimize the acid treatment process. Pretreatment with 6% (w/w) dilute sulfuric acid at 120°C for 120 min provided the highest reducing sugar yield of 267.57 g/kg SMS. No furfural was detected in the hydrolysates. Exposure to 20PFU of cellulase and 200 XU of xylanase per gram of pretreated SMS at 40°C resulted in the release of 79.85 g/kg or reducing sugars per kg acid pretreated SMS. The dilute sulfuric acid could be recycled to process fresh SMS four times. SMS hydrolysates neutralized with ammonium hydroxide, sodium hydroxide, or calcium hydroxide could be used as the carbon source for cultivation of Lactococcus lactis subsp. lactis W28 and a cell density of 2.9×10(11)CFU/mL could be obtained. The results provide a foundation for the development of value-added products based on SMS.


Asunto(s)
Agaricales/metabolismo , Celulasa/metabolismo , Lactococcus lactis/crecimiento & desarrollo , Ácidos Sulfúricos/metabolismo , Xilosidasas/metabolismo , Hidrólisis
10.
Amino Acids ; 39(3): 727-37, 2010 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-20174841

RESUMEN

GABA is a molecule of increasing nutraceutical interest due to its modulatory activity on the central nervous system and smooth muscle relaxation. Potentially probiotic bacteria can produce it by glutamate decarboxylation, but nothing is known about the physiological modifications occurring at the microbial level during GABA production. In the present investigation, a GABA-producing Lactococcus lactis strain grown in a medium supplemented with or without glutamate was studied using a combined transcriptome/proteome analysis. A tenfold increase in GABA production in the glutamate medium was observed only during the stationary phase and at low pH. About 30 genes and/or proteins were shown to be differentially expressed in glutamate-stimulated conditions as compared to control conditions, and the modulation exerted by glutamate on entire metabolic pathways was highlighted by the complementary nature of transcriptomics and proteomics. Most glutamate-induced responses consisted in under-expression of metabolic pathways, with the exception of glycolysis where either over- or under-expression of specific genes was observed. The energy-producing arginine deiminase pathway, the ATPase, and also some stress proteins were down-regulated, suggesting that glutamate is not only an alternative means to get energy, but also a protective agent against stress for the strain studied.


Asunto(s)
Perfilación de la Expresión Génica , Ácido Glutámico/metabolismo , Lactococcus lactis/metabolismo , Proteómica , Ácido gamma-Aminobutírico/metabolismo , Proteínas Bacterianas/genética , Proteínas Bacterianas/metabolismo , Regulación Bacteriana de la Expresión Génica , Lactococcus lactis/genética , Lactococcus lactis/crecimiento & desarrollo
11.
Int Rev Immunol ; 28(6): 465-86, 2009.
Artículo en Inglés | MEDLINE | ID: mdl-19954359

RESUMEN

Lactic acid bacteria are a group of taxonomically diverse, Gram-positive food-grade bacteria that have been safely consumed throughout history. The lactic acid bacterium Lactococcus lactis, well-known for its use in the manufacture of cheese, can be genetically engineered and orally formulated to deliver therapeutic proteins in the gastrointestinal tract. This review focuses on the genetic engineering of Lactococcus lactis to secrete high-quality, correctly processed bioactive molecules derived from a eukaryotic background. The therapeutic applications of these genetically modified strains are discussed, with special regards to immunomodulation.


Asunto(s)
Tracto Gastrointestinal/inmunología , Ingeniería Genética/métodos , Lactococcus lactis/genética , Tejido Linfoide/inmunología , Animales , Evaluación Preclínica de Medicamentos , Tracto Gastrointestinal/microbiología , Humanos , Enfermedades Inflamatorias del Intestino/genética , Enfermedades Inflamatorias del Intestino/microbiología , Enfermedades Inflamatorias del Intestino/terapia , Interleucina-10/genética , Interleucina-10/metabolismo , Lactococcus lactis/crecimiento & desarrollo , Lactococcus lactis/metabolismo , Péptidos/genética , Péptidos/metabolismo , Factor Trefoil-2
12.
Int J Food Microbiol ; 131(2-3): 183-8, 2009 May 31.
Artículo en Inglés | MEDLINE | ID: mdl-19339076

RESUMEN

Bile resistance is one of the basic characteristics of probiotic bacteria. The aim of this study was to investigate the characteristics of bile resistance in lactococci by studying the relationship between bile resistance and cellular fatty acid composition in lactococcci grown on different media. We determined the bile resistance of 14 strains in lactose-free M17 medium supplemented with either glucose only (GM17) or lactose only (LM17). Gas chromatographic analyses of free lipids extracted from the tested strains were used for determining their fatty acid composition. A correlation analysis of all strains grown in both media revealed significant positive correlations between bile resistance and relative contents of hexadecanoic acid and octadecenoic acid, and negative correlations between bile resistance and relative contents of hexadecenoic acid and C-19 cyclopropane fatty acid. It is also a fact that the fatty acids associated with bile resistance depended on species, strain, and/or growth medium. In L. lactis subsp. cremoris strains grown in GM17 medium, the bile-resistant strains had significantly more octadecenoic acid than the bile-sensitive strains. In LM17 medium, bile-resistant strains had significantly more octadecenoic acid and significantly less C-19 cyclopropane fatty acid than the bile-sensitive strains. In L. lactis subsp. lactis strains, bile resistances of some of the tested strains were altered by growth medium. Some strains were resistant to bile in GM17 medium but sensitive to bile in LM17 medium. Some strains were resistant in both media tested. The strains grown in GM17 medium had significantly more hexadecanoic acid and octadecenoic acid, and significantly less tetradecanoic acid, octadecadienoic acid and C-19 cyclopropane fatty acid than the strains grown in LM17 medium. In conclusion, the fatty acid compositions of the bile-resistant lactococci differed from those of the bile-sensitive ones. More importantly, our data suggest that altering their fatty acid composition (i.e. increased hexadecanoic acid and octadecenoic acid and decreased hexadecenoic acid and C-19 cyclopropane fatty acid) by changing growth conditions may be a useful way to enhance their bile resistance in lactococci.


Asunto(s)
Bilis/microbiología , Ácidos Grasos/análisis , Lactococcus lactis/química , Medios de Cultivo , Glucosa , Lactococcus lactis/efectos de los fármacos , Lactococcus lactis/crecimiento & desarrollo , Lactosa
13.
Arch Microbiol ; 190(4): 427-37, 2008 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-18523755

RESUMEN

The genome of Lactococcus lactis encodes a single long chain 3-ketoacyl-acyl carrier protein synthase. This is in contrast to its close relative, Enterococcus faecalis, and to Escherichia coli, both of which have two such enzymes. In E. faecalis and E. coli, one of the two long chain synthases (FabO and FabB, respectively) has a role in unsaturated fatty acid synthesis that cannot be satisfied by FabF, the other long chain synthase. Since L. lactis has only a single long chain 3-ketoacyl-acyl carrier protein synthase (annotated as FabF), it seemed likely that this enzyme must function both in unsaturated fatty acid synthesis and in elongation of short chain acyl carrier protein substrates to the C18 fatty acids found in the cellular phospholipids. We report that this is the case. Expression of L. lactis FabF can functionally replace both FabB and FabF in E. coli, although it does not restore thermal regulation of phospholipid fatty acid composition to E. coli fabF mutant strains. The lack of thermal regulation was predictable because wild-type L. lactis was found not to show any significant change in fatty acid composition with growth temperature. We also report that overproduction of L. lactis FabF allows growth of an L. lactis mutant strain that lacks the FabH short chain 3-ketoacyl-acyl carrier protein synthase. The strain tested was a derivative (called the fabH bypass strain) of the original fabH deletion strain that had acquired the ability to grow when supplemented with octanoate. Upon introduction of a FabF overexpression plasmid into this strain, growth proceeded normally in the absence of fatty acid supplementation. Moreover, this strain had a normal rate of fatty acid synthesis and a normal fatty acid composition. Both the fabH bypass strain that overproduced FabF and the wild type strain incorporated much less exogenous octanoate into long chain phospholipid fatty acids than did the fabH bypass strain. Incorporation of octanoate and decanoate labeled with deuterium showed that these acids were incorporated intact as the distal methyl and methylene groups of the long chain fatty acids.


Asunto(s)
3-Oxoacil-(Proteína Transportadora de Acil) Sintasa/genética , 3-Oxoacil-(Proteína Transportadora de Acil) Sintasa/metabolismo , Proteínas Bacterianas/genética , Proteínas Bacterianas/metabolismo , Lactococcus lactis/enzimología , Caprilatos/metabolismo , Ácidos Decanoicos/metabolismo , Enterococcus faecalis/enzimología , Enterococcus faecalis/genética , Escherichia coli/enzimología , Escherichia coli/genética , Ácidos Grasos/metabolismo , Eliminación de Gen , Prueba de Complementación Genética , Lactococcus lactis/química , Lactococcus lactis/genética , Lactococcus lactis/crecimiento & desarrollo , Redes y Vías Metabólicas , Modelos Biológicos , Fosfolípidos/metabolismo , Plásmidos
14.
Appl Biochem Biotechnol ; 121-124: 619-37, 2005.
Artículo en Inglés | MEDLINE | ID: mdl-15920268

RESUMEN

Nisin is a bacteriocin that inhibits the germination and growth of Gram-positive bacteria. With nisin expression related to growth conditions of Lactococcus lactis subsp. lactis, the effects of growth parameters, media components, and incubation time were studied to optimize expression. L. lactis ATCC 11454 was grown (100 rpm at 30 degrees C for 36 h) in both M17 and MRS standard broth media (pH 6.0-7.0) supplemented with sucrose (1.0-12.5 g/L), potassium phosphate (0.13 g/L), asparagine (0.5 g/L), and sucrose (0.24 g/L), and diluted 1:1 with liquid nonfat milk. Liquid nonfat milk, undiluted, was also used as another medium (9% total solids, pH 6.5). Nisin production was assayed by agar diffusion using Lactobacillus sake ATCC 15521 (30 degrees C for 24 h) as the sensitive test organism. The titers of nisin expressed and released in culture media were quantified and expressed in arbitrary units (AU/L of medium) and converted into known concentrations of "standard nisin" (Nisaplin, g/L). The detection of nisin activity was <0.01 AU/L in M17 and MRS broths, and 7.5 AU/L in M17 with 0.14% sucrose or 0.13% other supplements, and the activity increased to 142.5 AU/L in M17 diluted with liquid nonfat milk (1:1). The 25% milk added to either 25% M17 or 25% MRS provided the highest levels of nisin assayed.


Asunto(s)
Reactores Biológicos/microbiología , Técnicas de Cultivo de Célula/métodos , Lactococcus lactis/crecimiento & desarrollo , Lactococcus lactis/metabolismo , Leche/microbiología , Nisina/biosíntesis , Sacarosa/metabolismo , Animales , Proliferación Celular , Medios de Cultivo/metabolismo , Concentración de Iones de Hidrógeno , Leche/clasificación
15.
Nutr Clin Care ; 7(2): 69-74, 2004.
Artículo en Inglés | MEDLINE | ID: mdl-15481740

RESUMEN

Poi is a pasty starch made from the cooked, mashed corm of the taro plant (Colocasia esculenta L.). Originating in Asia, this root crop is now found primarily in tropical and subtropical regions and was a major dietary staple in the Pacific islands. We hypothesize that poi has potential use as a probiotic-defined by FAO/WHO as, "live microorganisms which when administered in adequate amounts confer a health benefit to the host." No scientific studies have explored the possibility of poi being used as a probiotic in medical nutrition therapy, however, an investigator determined that the predominant bacteria in poi are Lactococcus lactis (95%) and Lactobacilli (5%), both of which are lactic acid-producing bacteria. This investigator also reported that poi contains significantly more of these bacteria per gram than yogurt. To determine if poi is beneficial for certain health conditions, a literature search was conducted to find all available research studies in which poi was used as a complementary treatment. Documented evidence suggests that poi shows promise for use in infants with allergies or failure-to-thrive. However, to support previous findings, more research needs to be conducted with poi and its potential use as a probiotic.


Asunto(s)
Colocasia , Insuficiencia de Crecimiento/dietoterapia , Hipersensibilidad a los Alimentos/prevención & control , Fitoterapia/métodos , Raíces de Plantas , Preescolar , Colocasia/microbiología , Femenino , Humanos , Lactante , Recién Nacido , Recien Nacido Prematuro , Lactobacillus/crecimiento & desarrollo , Lactococcus lactis/crecimiento & desarrollo , Masculino , Raíces de Plantas/microbiología , Probióticos/uso terapéutico
16.
J Basic Microbiol ; 44(4): 305-16, 2004.
Artículo en Inglés | MEDLINE | ID: mdl-15266603

RESUMEN

Bacteriocin ST34BR, a small polypeptide of 2.9 kDa produced by Lactococcus lactis subsp. lactis ST34BR, inhibits the growth of Enterococcus faecalis, Escherichia coli, Lactobacillus plantarum, Lactobacillus casei, Pseudomonas aeruginosa and Staphylococcus aureus. MRS broth, adjusted to pH 6.0 yielded 6,400 AU/ml, compared to 400 AU/ml recorded in BHI broth, M17 broth, 10% (w/v) soy milk, and 8% and 10% (w/v) molasses. At pH of 4.5 only 800 AU/ml was produced. Based on comparative studies in MRS broth, without organic nitrogen, supplemented with different combinations of tryptone, meat extract and yeast extract, tryptone was identified as the stimulating nitrogen compound. Growth in the presence of 20 g/l glucose, maltose, mannose or sucrose yielded bacteriocin levels of 6,400 AU/ml, whereas the same concentration of lactose and fructose yielded 3,200 AU/ml and 1,600 AU/ml, respectively. No difference in bacteriocin ST34BR activity was recorded in MRS broth supplemented with 2 g/l K2HPO4 and 2 g/l, 5 g/l, 10 g/l or 50 g/l KH2PO4. However, 20 g/l KH2PO4 increased bacteriocin ST34BR production to 12,800 AU/ml. Glycerol at 1g/l to 10 g/l in MRS broth reduced bacteriocin activity to 3,200 AU/ml, whilst 20 g/l and 50 g/l yielded only 1,600 AU/ml. The presence of cyanocobalamin, L-ascorbic acid, thiamine and DL-6,8-thioctic acid in MRS broth at 1.0 ppm, respectively, did not result in increased activity levels.


Asunto(s)
Bacteriocinas/biosíntesis , Cerveza/microbiología , Hordeum/microbiología , Lactococcus lactis/crecimiento & desarrollo , Animales , Bacterias/efectos de los fármacos , Bacteriocinas/farmacología , Bovinos , Medios de Cultivo , Humanos , Lactococcus lactis/metabolismo , Pruebas de Sensibilidad Microbiana
17.
Appl Environ Microbiol ; 69(6): 3061-8, 2003 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-12788699

RESUMEN

Aminotransferases, which catalyze the last step of biosynthesis of most amino acids and the first step of their catabolism, may be involved in the growth of Lactococcus lactis in milk. Previously, we isolated two aminotransferases from L. lactis, AraT and BcaT, which are responsible for the transamination of aromatic amino acids, branched-chain amino acids, and methionine. In this study, we demonstrated that double inactivation of AraT and BcaT strongly reduced the growth of L. lactis in milk. Supplementation of milk with amino acids and keto acids that are substrates of both aminotransferases did not improve the growth of the double mutant. On the contrary, supplementation of milk with isoleucine or a dipeptide containing isoleucine almost totally inhibited the growth of the double mutant, while it did not affect or only slightly affected the growth of the wild-type strain. These results suggest that AraT and BcaT play a major role in the growth of L. lactis in milk by degrading the intracellular excess isoleucine, which is responsible for the growth inhibition. The growth inhibition by isoleucine is likely to be due to CodY repression of the proteolytic system, which is necessary for maximal growth of L. lactis in milk, since the growth of the CodY mutant was not affected by addition of isoleucine to milk. Moreover, we demonstrated that AraT and BcaT are part of the CodY regulon and therefore are regulated by nutritional factors, such as the carbohydrate and nitrogen sources.


Asunto(s)
Regulación Bacteriana de la Expresión Génica , Lactococcus lactis/crecimiento & desarrollo , Leche/microbiología , Proteínas Represoras/metabolismo , Transaminasas/metabolismo , Aminoácidos Aromáticos/metabolismo , Aminoácidos de Cadena Ramificada/metabolismo , Animales , Proteínas Bacterianas/genética , Proteínas Bacterianas/metabolismo , Medios de Cultivo , Isoleucina/metabolismo , Lactococcus lactis/enzimología , Mutación , Proteínas Represoras/genética
18.
Can J Microbiol ; 48(7): 626-34, 2002 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-12224561

RESUMEN

The effectiveness of yeast extracts (YE) and potato extracts (PE) to promote growth of seven lactic cultures was evaluated by automated spectrophotometry (AS). Two aspects of the growth curve were analysed: (1) maximum biomass obtained (using ODmax) and (2) highest specific growth rate mu(max)) Eleven lots from the same PE-manufacturing process were examined for lot-to-lot variability. The ODmax values of three of the seven strains were significantly affected by lot source, but mu(max) was not significantly affected. The growth of bacteria was systematically lower in base medium containing 100% PE than in base medium containing 100% YE for both ODmax or mu(max) data, which could be related to the lower content in nitrogen-based compounds in PE. In AS assays, highest OD values for Lactobacillus casei EQ28, Lactobacillus rhamnosus R-011, Lactobacillus plantarum EQ12, and Streptococcus thermophilus R-083 were obtained with a mixture of PE and YE. Fermentations (2 L) were also carried out to determine the accuracy of AS to predict biomass levels obtained under fermentation trials. In these fermentations, replacement of 50% YE with PE was shown to enable good growth of S. thermophilus. With L. rhamnosus R-011, a high correlation (R2 = 0.95) was found between ODmax data obtained in the AS assays and that of the 2-L bioreactor when the same growth medium was used for both series of fermentations. However, AS was not as efficient when industrial media were used for the bioreactor assays. The relationship was still good for ODmax between AS data and that of the bioreactor data with L. rhamnosus R-011 in industrial LBS medium (R2 = 0.87), but was very poor with the S. thermophilus R-083 on Rosell #43 industrial medium (R2 = 0.33). Since PE cost 40% less than YE, there are strong economic advantages in considering such a partial replacement of YE by PE.


Asunto(s)
Medios de Cultivo/química , Lactobacillus/crecimiento & desarrollo , Streptococcaceae/crecimiento & desarrollo , Técnicas Bacteriológicas , Biomasa , Reactores Biológicos , Fermentación , Lactococcus lactis/crecimiento & desarrollo , Pediococcus/crecimiento & desarrollo , Extractos Vegetales , Saccharomyces cerevisiae , Solanum tuberosum , Streptococcus/crecimiento & desarrollo
19.
Biotechnol Bioeng ; 78(1): 11-6, 2002 Apr 05.
Artículo en Inglés | MEDLINE | ID: mdl-11857275

RESUMEN

Uniformly (13)C labeled glucose was fed to a lactic acid bacterium growing on a defined medium supplemented with all proteinogenic amino acids except glutamate. Aspartate stemming from the protein pool and from the extracellular medium was enriched with (13)C disclosing a substantial de novo biosynthesis of this amino acid simultaneous to its uptake from the growth medium and a rapid exchange flux of aspartate over the cellular membrane. Phenylalanine, alanine, and threonine were also synthesized de novo in spite of their presence in the growth medium.


Asunto(s)
Aminoácidos/biosíntesis , Aminoácidos/farmacocinética , Ácido Aspártico/metabolismo , Lactococcus lactis/metabolismo , Modelos Biológicos , Alanina/biosíntesis , Alanina/farmacocinética , Ácido Aspártico/química , Biomasa , Membrana Celular/metabolismo , Simulación por Computador , Medios de Cultivo , Cromatografía de Gases y Espectrometría de Masas , Ácido Glutámico/metabolismo , Marcaje Isotópico/métodos , Lactococcus lactis/genética , Lactococcus lactis/crecimiento & desarrollo , Modelos Químicos , Fenilalanina/biosíntesis , Fenilalanina/farmacocinética , Treonina/biosíntesis , Treonina/farmacocinética
20.
Biosci Biotechnol Biochem ; 65(2): 330-7, 2001 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-11302166

RESUMEN

Lactic acid fermentation of cooked rice and rice koji by supplementation with soybean extract (SBE) and its application to rice miso fermentation were investigated. By supplementing the cooked rice with SBE, lactic acid bacteria (LAB) grew well without any unfavorable effects on the rice such as off-flavor or coloration. Lactococcus lactis subsp. lactis IFO12007 (Lc. lactis, a producer of the bacteriocin nisin) proliferated at 10(8 to approximately 9) cells/g after 24 h of incubation and produced high activity of nisin. The fermented rice with Lc. lactis strongly inhibited not only Bacillus subtilis ATCC19659 but also the other Bacillus strains. While some strains of LAB markedly inhibited the growth of Asp. oryzae, resulting in failure of koji fermentation, Lc. lactis did not affect the growth of these molds. When Lc. lactis was used for rice miso fermentation as a lactic acid starter culture, Lc. lactis rapidly proliferated and produced high nisin activity of 6,400 IU/g, in the steamed rice, resulting in complete growth inhibition of B. subtilis, which had been inoculated at the beginning of the koji fermentation. The rice miso after 12 weeks of aging had a suitable pH, and favorable taste and color. Furthermore, hyposalting of rice miso could be done without difficulty by lactic acid fermentation of both rice and soybeans.


Asunto(s)
Bacillus subtilis/crecimiento & desarrollo , Lactococcus lactis/crecimiento & desarrollo , Lactococcus lactis/metabolismo , Nisina/biosíntesis , Oryza/microbiología , Recuento de Colonia Microbiana , Fermentación , Microbiología de Alimentos , Tecnología de Alimentos , Ácido Láctico/metabolismo , Lactococcus lactis/ultraestructura , Microscopía Electrónica de Rastreo , Oryza/ultraestructura , Extractos Vegetales/farmacología , Glycine max
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA